In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection.

Gelijkaardige items

• In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae.
  door: Agacfidan, A, et al.
  Gepubliceerd in: (1993)
• In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii.
  door: Chang, H R, et al.
  Gepubliceerd in: (1988)
• In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin.
  door: Barry, A L, et al.
  Gepubliceerd in: (1988)
• Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution.
  door: Girard, A E, et al.
  Gepubliceerd in: (1987)
• Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms.
  door: Retsema, J, et al.
  Gepubliceerd in: (1987)